NCT06343883

Brief Summary

Investigating the relationship between input pressure of low-intensity focused ultrasound and an evoked potential in both eeg and fMRI.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Oct 2024Jul 2026

First Submitted

Initial submission to the registry

March 20, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 3, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

October 16, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

December 15, 2025

Status Verified

December 1, 2025

Enrollment Period

1.7 years

First QC Date

March 20, 2024

Last Update Submit

December 8, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Report of Symptoms Questionnaire

    questionnaire of symptomology administered pre and post intervention.

    pre/post intervention and 1 week post intervention.

  • MRI

    pre and post structural MRI collection for cohort one - evaluated by Neuroradiologist for safety considerations. Primarily looking to rule out any evidence of bleeds.

    pre and post intervention in cohort 1

Secondary Outcomes (2)

  • EEG

    throughout study visits in cohort 2 - approximately 2 hours per visit across 3 study visits (~2 weeks).

  • fMRI

    throughout study visits in cohort 3 - approximately 2 hours per visit across 3 study visits (~2 weeks).

Study Arms (3)

Safety Check - high pressure application

EXPERIMENTAL

Small cohort to be collected prior to other study cohorts. Highest of 3 pressures of interest will be applied to the S1 (somatosensory cortex) with a follow-up MRI conducted 24-72 hours post.

Device: low-intensity focused ultrasound - high pressure

EEG

EXPERIMENTAL

Electrical stimulation utilized to generate SEPs, performed pre and post LIFU application. One of three LIFU pressures will be applied. One per study visit (3), randomized order. EEG collected throughout visit (outcome measure).

Device: low-intensity focused ultrasound - low pressureDevice: low-intensity focused ultrasound - medium pressureDevice: low-intensity focused ultrasound - high pressure

fMRI

EXPERIMENTAL

Electrical stimulation utilized to generate SEPs, performed pre and post LIFU application. One of three LIFU pressures will be applied. One per study visit (3), randomized order. fMRI collected throughout visit (outcome measure).

Device: low-intensity focused ultrasound - low pressureDevice: low-intensity focused ultrasound - medium pressureDevice: low-intensity focused ultrasound - high pressure

Interventions

low-intensity focused ultrasound applied to the S1.

EEGfMRI

low-intensity focused ultrasound applied to the S1.

EEGfMRI

low-intensity focused ultrasound applied to the S1.

EEGSafety Check - high pressure applicationfMRI

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Understand and speak English

You may not qualify if:

  • Claustrophobia (scanning environment may be uncomfortable).
  • Contraindications to MRI: including pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants.
  • Contraindications to CT: pregnancy
  • Active medical disorder or treatment with potential CNS effects (e.g. Alzheimer's)
  • History of neurologic disorder. (e.g. Parkinson's, Epilepsy, or Essential Tremor)
  • History of head injury resulting in loss of consciousness for \>10 minutes.
  • History of alcohol or drug dependence (through self-report).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fralin Biomedical Research Institute at VTC

Roanoke, Virginia, 24016, United States

Location

MeSH Terms

Conditions

Nociceptive Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking, no sham. All subjects will receive all conditions, all of which are active.
Purpose
BASIC SCIENCE
Intervention Model
SEQUENTIAL
Model Details: Primary cohort (safety) will be collected prior to full study collection. Primary collection will involve highest pressure application and follow-up safety scans (MRI) to be reviewed by a Neuroradiologist. Once cleared - parallel design will be utilized for eeg and fMRI cohorts. Both cohorts will receive 3 LIFU pressures randomized over 3 study visits. Electrical stimulations will be applied pre and post LIFU administration to induce somatosensory evoked potentials (SEPs).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 20, 2024

First Posted

April 3, 2024

Study Start

October 16, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

December 15, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations